Hristo Taskov

526 total citations
27 papers, 415 citations indexed

About

Hristo Taskov is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Hristo Taskov has authored 27 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Hristo Taskov's work include Monoclonal and Polyclonal Antibodies Research (8 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (4 papers). Hristo Taskov is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (4 papers). Hristo Taskov collaborates with scholars based in Bulgaria, Germany and United States. Hristo Taskov's co-authors include Maria Nikolova, Andrej Shevchenko, Assen Roguev, Anna Shevchenko, A. Francis Stewart, Stoyno Stoynov, Roumiana Markova, Massimo Amicosante, Cesare Saltini and Wolfgang Domzig and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Hristo Taskov

24 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hristo Taskov Bulgaria 11 177 106 90 89 48 27 415
Shichina Kannambath United Kingdom 11 222 1.3× 147 1.4× 100 1.1× 106 1.2× 38 0.8× 15 482
Jumpei Asano Japan 9 165 0.9× 185 1.7× 50 0.6× 104 1.2× 70 1.5× 14 442
Gaël Vidricaire Canada 7 139 0.8× 66 0.6× 75 0.8× 63 0.7× 20 0.4× 8 356
Assefa Wondimu United States 14 175 1.0× 177 1.7× 150 1.7× 146 1.6× 69 1.4× 17 461
Yasuo Hitsumoto Japan 12 188 1.1× 203 1.9× 60 0.7× 70 0.8× 37 0.8× 42 509
E. Yamada Japan 14 199 1.1× 63 0.6× 50 0.6× 179 2.0× 24 0.5× 26 415
Hideyuki Kato Japan 9 102 0.6× 73 0.7× 72 0.8× 162 1.8× 58 1.2× 17 392
Seh‐Ching Lin United States 11 81 0.5× 51 0.5× 78 0.9× 46 0.5× 102 2.1× 16 374
Yuki Nishimura‐Sakurai Japan 12 172 1.0× 223 2.1× 124 1.4× 258 2.9× 14 0.3× 18 617
Aki Imai‐Matsushima Germany 8 143 0.8× 188 1.8× 114 1.3× 93 1.0× 159 3.3× 8 456

Countries citing papers authored by Hristo Taskov

Since Specialization
Citations

This map shows the geographic impact of Hristo Taskov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hristo Taskov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hristo Taskov more than expected).

Fields of papers citing papers by Hristo Taskov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hristo Taskov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hristo Taskov. The network helps show where Hristo Taskov may publish in the future.

Co-authorship network of co-authors of Hristo Taskov

This figure shows the co-authorship network connecting the top 25 collaborators of Hristo Taskov. A scholar is included among the top collaborators of Hristo Taskov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hristo Taskov. Hristo Taskov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taskov, Hristo, et al.. (2024). Guardians of immunity: NK cell-mediated defense in COVID-19 and post-COVID scenarios. SHILAP Revista de lepidopterología. 66(1). 12–18. 1 indexed citations
2.
Taskov, Hristo, et al.. (2023). ASSESSMENT OF SARS-COV-2 SPECIFIC B-CELL IMMUNE MEMORY: EVIDENCE FOR PERSISTENCE UP TO 1 YEAR POST-INFECTION. SHILAP Revista de lepidopterología. 50(3). 14–18.
3.
Alexiev, Ivailo, Danail Beshkov, Anupama Shankar, et al.. (2013). Detailed Molecular Epidemiologic Characterization of HIV-1 Infection in Bulgaria Reveals Broad Diversity and Evolving Phylodynamics. PLoS ONE. 8(3). e59666–e59666. 17 indexed citations
4.
Nikolova, Maria, et al.. (2012). Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection. Diagnostic Microbiology and Infectious Disease. 75(3). 277–281. 63 indexed citations
5.
Mihaylova, Nikolina, Elisaveta Voynova, Andrey Tchorbanov, et al.. (2007). Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their Fc IIb receptor. International Immunology. 20(2). 165–175. 15 indexed citations
6.
Taskov, Hristo, et al.. (2006). Comparision of two‐flow cytometry methods for basophil degranulation in patients sensitized to grass pollen. Allergy. 61(9). 1078–1083. 9 indexed citations
7.
Petrunov, Bogdan, et al.. (2006). Cellular and humoral systemic and mucosal immune responses stimulated in volunteers by an oral polybacterial immunomodulator “Dentavax”. International Immunopharmacology. 6(7). 1181–1193. 22 indexed citations
8.
Roguev, Assen, Andrej Shevchenko, Hristo Taskov, et al.. (2005). Uncoupling of Unwinding from DNA Synthesis Implies Regulation of MCM Helicase by Tof1/Mrc1/Csm3 Checkpoint Complex. Journal of Molecular Biology. 347(3). 509–521. 111 indexed citations
9.
Nikolova, Maria, et al.. (2005). The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients. Cellular Immunology. 237(2). 96–105. 22 indexed citations
10.
Stonehouse, Timothy J., David A. Fox, Antoni Gayà, et al.. (2000). Novel molecular mechanisms of dendritic cell-induced T cell activation. International Immunology. 12(7). 1051–1061. 52 indexed citations
11.
Nikolova, Maria, et al.. (1998). Levels of expression of CAF7 (CD98) have prognostic significance in adult acute leukemia. Leukemia Research. 22(1). 39–47. 8 indexed citations
12.
Taskov, Hristo, et al.. (1997). Humoral and Cellular Immune Response to Elastin in Patients with Systemic Sclerosis. Autoimmunity. 25(4). 233–241. 24 indexed citations
14.
Taskov, Hristo, et al.. (1996). Levels of CAF7 (CD98) expression correlate with the complete remission duration in childhood acute leukemia. Leukemia Research. 20(1). 75–79. 5 indexed citations
15.
Fichorova, Raina N., et al.. (1995). Detection of Antibodies Toward Epididymal Sperm Antigens—An Obligatory Step in Evaluation of Human Immunologic Infertility?. American Journal of Reproductive Immunology. 33(5). 341–349. 8 indexed citations
16.
Taskov, Hristo, et al.. (1995). Immunological subtypes of childhood acute lymphoblastic leukemia in Bulgaria. Leukemia Research. 19(11). 877–881. 10 indexed citations
17.
Nikolova, Maria & Hristo Taskov. (1994). Monoclonal Antibody 1D8 Detects an Activation-Related Molecule on Human B Lymphocytes and on a Minor T-Lymphocyte Subpopulation. Hybridoma. 13(4). 271–279. 1 indexed citations
18.
Pashov, Anastas & Hristo Taskov. (1994). Preparation and Characterization of a New Monoclonal Antibody CAF7 Specific for a Leukocyte Activation Antigen. Hybridoma. 13(3). 229–236. 2 indexed citations
19.
20.
Taskov, Hristo, et al.. (1993). Reproducibility of Estimation of CD3, CD4 and CD8 Reference Ranges Using Different Monoclonal Antibodies. Biologicals. 21(3). 215–220. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026